<DOC>
	<DOCNO>NCT01553344</DOCNO>
	<brief_summary>The aim study determine serum sclerostin level change serum sclerostin level patient Vitamin D deficiency treat calcium vitamin D. Healthy premenopausal Patients Vitamin D deficiency diagnose routinely treated calcium vitamin D include study . This observational study . The serum sclerostin level measure Vitamin D treatment .</brief_summary>
	<brief_title>Serum Sclerostin Level &amp; Treatment Vitamin D Deficiency</brief_title>
	<detailed_description>This study prospective , observational , single-center study . Ethical approval obtain Institutional Review Board . This study complete patient Vitamin D deficiency . An intravenous cannula insert antecubital vein . Blood sample obtain treatment . Serum collect centrifuge 15 minute 1000Xg within 30 minute collection . Aliquots serum add eppendorf tube store -20Â°C . Serum sclerostin level measure use Human Sclerostin ELISA kit ( Cusabio , Catalog No : CSB-E13146h , Newark , DE , USA ) . All assay perform accord manufacturer 's instruction . The minimum detectable concentration human sclerostin typically &lt; 0.012 ng/ml . Intra-assay precision less 8 % .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Premenopausal Serum 25 ( OH ) D &lt; 10 ng/mL Anemia Tumorinduced osteomalacia ( hypophosphatemia ) Hypothyroidism Hepatic / renal disease Primary hyperparathyroidism Fibromyalgia Polymyalgia rheumatica Serum 25 ( OH ) D &gt; 10 ng/mL Vitamin D calcium treatment commence prior study participation</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>sclerostin</keyword>
	<keyword>osteomalacia</keyword>
	<keyword>vitamin D deficiency</keyword>
</DOC>